120 related articles for article (PubMed ID: 32092376)
1. The age of procalcitonin: potential pitfalls in critically ill patients with SJS/TEN. A comment on "Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients".
Jacobsen AA; Pearson DR
J Am Acad Dermatol; 2020 Jun; 82(6):e247. PubMed ID: 32092376
[No Abstract] [Full Text] [Related]
2. Reply to: "The age of procalcitonin: Potential pitfalls in critically ill patients with SJS/TEN. A comment on 'Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients'".
Koh HK; Lee HY
J Am Acad Dermatol; 2020 Jun; 82(6):e249. PubMed ID: 32092373
[No Abstract] [Full Text] [Related]
3. Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients.
Koh HK; Chai ZT; Tay HW; Fook-Chong S; Choo KJL; Oh CC; Yeo YW; Koh HY; Pang SM; Lee HY
J Am Acad Dermatol; 2019 Sep; 81(3):686-693. PubMed ID: 31195022
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang Q; Tian XB; Liu W; Zhang LX
J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
[TBL] [Abstract][Full Text] [Related]
5. Predicting sepsis in Stevens-Johnson syndrome-toxic epidermal necrolysis: Should dermatologists be pro-procalcitonin?
Heymann WR
J Am Acad Dermatol; 2019 Sep; 81(3):684-685. PubMed ID: 31420075
[No Abstract] [Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
Tartarone A; Lerose R
Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465
[TBL] [Abstract][Full Text] [Related]
7. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
[TBL] [Abstract][Full Text] [Related]
8. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gilbert M; Scherrer LA
Dermatol Ther; 2019 Jan; 32(1):e12758. PubMed ID: 30285308
[TBL] [Abstract][Full Text] [Related]
10. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
12. Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink.
Frey N; Bircher A; Bodmer M; Jick SS; Meier CR; Spoendlin J
Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):429-436. PubMed ID: 27868282
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
Sane SP; Bhatt AD
J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Sato S; Kanbe T; Tamaki Z; Furuichi M; Uejima Y; Suganuma E; Takano T; Kawano Y
Pediatr Int; 2018 Aug; 60(8):697-702. PubMed ID: 29888432
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L
J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
19. [Clinical assessment of the risk of bacteremia and the value of skin cultures during Stevens-Johnson syndrome and toxic epidermal necrolysis].
de Prost N; Duong TA; Brun-Buisson C; Roujeau JC
Ann Dermatol Venereol; 2010 Oct; 137(10):651-2. PubMed ID: 20932449
[No Abstract] [Full Text] [Related]
20. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A; Abe R
F1000Res; 2020; 9():. PubMed ID: 32595945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
